Takeda Pharmaceutical (TAK) Cash from Operations (2018 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Cash from Operations of 800694261.84 for Q2 2026, down 46.22% year-over-year from 1488811184.32 in Q2 2025, and down 49.18% quarter-over-quarter from 1575581736.62 in Q1 2026.
Takeda Pharmaceutical (TAK) Cash from Operations (2018 - 2026) Analysis & Trends
Takeda Pharmaceutical's Cash from Operations history runs 9 years deep, the most recent figure standing at 800694261.84 for Q2 2026.
- In Q2 2026, Cash from Operations fell 46.22% year-over-year to 800694261.84; the TTM figure through Jun 2026 stood at 7368572734.53 (changed 0.21% YoY), while the FY2026 annual figure was 8064779691.9, up 16.2% from the prior year.
- Cash from Operations for Q2 2026 stood at 800694261.84, down from 1575581736.62 in the prior quarter.
- The five-year high for Cash from Operations was 3231846931.85 in Q1 2022, with the low at 651383776.08 in Q2 2022.
- The 5-year median for Cash from Operations is 1587845073.36 (2022), against an average of 1728804862.49.
- The sharpest annual moves came in 2023 and 2024: Cash from Operations tumbled 62.99% in 2023, then jumped 154.78% in 2024.
- Takeda Pharmaceutical's Cash from Operations stood at 2677225361.33 in 2022, then sank by 62.99% to 990775096.48 in 2023, then soared by 154.78% to 2524260483.73 in 2024, then slipped by 3.92% to 2425354411.72 in 2025, then tumbled by 66.99% to 800694261.84 in 2026.
- Business Quant data shows TAK's Cash from Operations at 800694261.84 in Q2 2026, 1575581736.62 in Q1 2026, and 2425354411.72 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn | 145.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 800.69 Mn |
| Jun 30, 2026 | 800.69 Mn |
| Mar 31, 2026 | 1.58 Bn |
| Mar 31, 2026 | 1.58 Bn |
| Dec 31, 2025 | 2.43 Bn |
| Dec 31, 2025 | 2.43 Bn |
| Sep 30, 2025 | 2.57 Bn |
| Sep 30, 2025 | 2.57 Bn |
| Jun 30, 2025 | 1.49 Bn |
| Jun 30, 2025 | 1.49 Bn |
| Mar 31, 2025 | 1.46 Bn |
| Mar 31, 2025 | 1.46 Bn |
| Dec 31, 2024 | 2.52 Bn |
| Dec 31, 2024 | 2.52 Bn |
| Sep 30, 2024 | 1.88 Bn |
| Sep 30, 2024 | 1.88 Bn |
| Jun 30, 2024 | 1.09 Bn |
| Jun 30, 2024 | 1.09 Bn |
| Mar 31, 2024 | 1.88 Bn |
| Mar 31, 2024 | 1.88 Bn |